ArticleNature genetics2025
Author Correction: Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes.
Abstract readPublished Erratum
In one paragraph
Article in Nature genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
59 authors.
Sheri SkergetIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Daniel PenaherreraIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Ajai ChariTisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.ORCID http://orcid.org/0000-0002-0405-7480
Sundar JagannathTisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.ORCID http://orcid.org/0000-0003-2934-6518
David S SiegelHackensack University Medical Center, Hackensack, NJ, USA.ORCID http://orcid.org/0000-0002-3604-2574
Ravi VijDivision of Oncology, Washington University, St. Louis, MO, USA.
Gregory OrloffVirginia Cancer Specialists, Fairfax, VA, USA.
Andrzej JakubowiakUniversity of Chicago Medical Center, Chicago, IL, USA.
Ruben NiesvizkyWeill Cornell Medicine, New York City, NY, USA.
Darla LilesDivision of Hematology/Oncology, East Carolina University, Greenville, NC, USA.ORCID http://orcid.org/0000-0003-1480-7887
Jesus BerdejaSarah Cannon Research Institute, Nashville, TN, USA.ORCID http://orcid.org/0000-0003-4362-0376
Moshe LevyBaylor Scott and White Research Institute, Dallas, TX, USA.
Jeffrey WolfDepartment of Medicine, UCSF Medical Center, San Francisco, CA, USA.
Saad Z UsmaniLevine Cancer Institute, Charlotte, NC, USA.ORCID http://orcid.org/0000-0002-5484-8731
MMRF CoMMpass Network
Austin W ChristoffersonIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Sara NasserIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Jessica L AldrichIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Christophe LegendreIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Brooks BenardIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.ORCID http://orcid.org/0000-0001-7154-744X
Chase MillerIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Bryce TurnerIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Ahmet KurdogluIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Megan WashingtonIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Venkata YellapantulaIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.ORCID http://orcid.org/0000-0003-1592-7741
Jonathan R AdkinsIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Lori CuyuganIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Martin BoatengIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Adrienne HellandIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Shari KymanIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.ORCID http://orcid.org/0000-0001-5386-5866
Jackie McDonaldIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Rebecca ReimanIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Kristi StephensonIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Erica TassoneIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Alex BlanskiVan Andel Institute, Grand Rapids, MI, USA.
Brianne LivermoreVan Andel Institute, Grand Rapids, MI, USA.
Meghan KirchhoffVan Andel Institute, Grand Rapids, MI, USA.
Daniel C RohrerVan Andel Institute, Grand Rapids, MI, USA.ORCID http://orcid.org/0000-0002-1784-9196
Mattia D'AgostinoDivision of Hematology, AOU Città della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, Torino, Italy.
Manuela GambellaDivision of Hematology, AOU Città della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, Torino, Italy.
Kimberly CollisonSpectrum Health, Grand Rapids, MI, USA.
Jennifer StumphSpectrum Health, Grand Rapids, MI, USA.ORCID http://orcid.org/0000-0003-2423-0241
Pam KiddSpectrum Health, Grand Rapids, MI, USA.
Andrea DonnellyPrecision for Medicine, Flemington, NJ, USA.
Barbara ZauggPrecision for Medicine, Flemington, NJ, USA.
Maureen TooneInStat Services, Chatham, NJ, USA.
Kyle McBrideInStat Services, Chatham, NJ, USA.
Mary DeRomeMultiple Myeloma Research Foundation, Norwalk, CT, USA.
Jennifer RogersMultiple Myeloma Research Foundation, Norwalk, CT, USA.
David CraigIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Winnie S LiangIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.ORCID http://orcid.org/0000-0002-5698-7735
Norma C GutierrezDepartment of Hematology, University Hospital of Salamanca, IBSAL, Cancer Research Center-IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain.ORCID http://orcid.org/0000-0001-5834-9510
Scott D JewellVan Andel Institute, Grand Rapids, MI, USA.ORCID http://orcid.org/0000-0001-9469-6261
John CarptenIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
Kenneth C AndersonDana-Farber Cancer Institute, Harvard Cancer Center, Boston, MA, USA.ORCID http://orcid.org/0000-0002-6418-0886
Hearn Jay ChoTisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
Daniel AuclairMultiple Myeloma Research Foundation, Norwalk, CT, USA.ORCID http://orcid.org/0000-0001-5151-3058
Sagar LonialDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA. sloni01@emory.edu.
Jonathan J KeatsIntegrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA. jkeats@tgen.org.ORCID http://orcid.org/0000-0003-4375-7399
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.